The startup that wants to cure diseases and slow aging, with the help of AI | Semafor
Insilico Medicine used artificial intelligence to discover a potential new treatment for idiopathic pulmonary fibrosis.
Insilico's CEO believes that AI has the potential to create hyper-targeted drugs and extend human life by inhibiting cells associated with aging. [ more ]